InvestSMART

Emerald Resources NL (ASX: EMR) - Announcements

Current share price for EMR : $6.460 0.18 (2.71%)+

ASX company news and announcements for Emerald Resources NL (EMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emerald Resources NL (EMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emerald Resources NL (EMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emerald Resources NL (EMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4,286 EMR Backed Manda Resources to Consolidate QLD Gold Assets 3 Jun 2026 9:29AM $6.040 $6.460 risen by 6.95%
$4,286 PGO: Strategic Demerger of North Qld Assets 3 Jun 2026 9:11AM $6.040 $6.460 risen by 6.95%
$4,286 Works Approval Granted for Dingo Range Gold Project 6 May 2026 8:24AM $5.730 $6.460 risen by 12.74%
$4,286 Application for quotation of securities - EMR 1 May 2026 6:45PM $5.850 $6.460 risen by 10.43%
$4,286 Option Exercise 1 May 2026 6:03PM $5.850 $6.460 risen by 10.43%
$4,286 Change in substantial holding 1 May 2026 8:20AM $5.780 $6.460 risen by 11.76%
$4,286 Application for quotation of securities - EMR 30 Apr 2026 6:43PM $5.780 $6.460 risen by 11.76%
$4,286 Option Exercise 30 Apr 2026 6:42PM $5.780 $6.460 risen by 11.76%
$4,286 Quarterly Report 23 Apr 2026 8:25AM $6.420 $6.460 risen by 0.62%
$4,286 Exploration and Resource Drilling Update 21 Apr 2026 8:44AM $6.540 $6.460 fallen by 1.22%
$4,286 March 2026 Quarterly Production Update 10 Apr 2026 8:39AM $6.210 $6.460 risen by 4.03%
$4,286 Becoming a substantial holder 26 Mar 2026 6:20PM $5.020 $6.460 risen by 28.69%
$4,286 Ceasing to be a substantial holder 25 Mar 2026 8:13AM $4.710 $6.460 risen by 37.15%
$4,286 Becoming a substantial holder 20 Mar 2026 3:09PM $5.035 $6.460 risen by 28.30%
$4,286 Application for quotation of securities - EMR 18 Mar 2026 7:53PM $5.730 $6.460 risen by 12.74%
$4,286 Option Exercise 18 Mar 2026 7:53PM $5.730 $6.460 risen by 12.74%
$4,286 Ceasing to be a substantial holder 18 Mar 2026 4:12PM $5.730 $6.460 risen by 12.74%
$4,286 Euroz Hartleys Conference - Investor Presentation 18 Mar 2026 9:03AM $5.780 $6.460 risen by 11.76%
$4,286 Becoming a substantial holder 17 Mar 2026 5:40PM $5.780 $6.460 risen by 11.76%
$4,286 Ceasing to be a substantial holder 3 Mar 2026 4:55PM $6.880 $6.460 fallen by 6.10%
$4,286 Becoming a substantial holder 27 Feb 2026 5:08PM $7.080 $6.460 fallen by 8.76%
$4,286 Leadership Strengthened with Josh Redmond Appointed COO 24 Feb 2026 9:11AM $6.660 $6.460 fallen by 3%
$4,286 Half Yearly Report and Accounts 24 Feb 2026 8:14AM $6.660 $6.460 fallen by 3%
$4,286 Application for quotation of securities - EMR 13 Feb 2026 4:59PM $6.370 $6.460 risen by 1.41%
$4,286 Notification regarding unquoted securities - EMR 13 Feb 2026 4:59PM $6.370 $6.460 risen by 1.41%

51 - 75 of 1031 results

Page 3 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.